Sort
35,931 grants matching “parkinsons”
Functions and connections of inhibitory reticulospinal locomotor systems
$380,625Veronique Vanderhorst · Beth Israel Deaconess Medical Center · R01 · FY2015 · NS
Functions and connections of inhibitory reticulospinal locomotor systems
$380,625Veronique Vanderhorst · Beth Israel Deaconess Medical Center · R01 · FY2016 · NS
Technology Research and Development Project 3 (Characterizing and Modifying Cortical Processes)
$380,614Gerwin Schalk · Wadsworth Center · P41 · FY2019 · EB
High Resolution Characterization of Receptor Signaling and Regulation
$380,601Barbara A Baird · Cornell University · R01 · FY2018 · GM
Analysis of Septin Structure and Function
$380,581Erfei Bi · University Of Pennsylvania · R01 · FY2019 · GM
Analysis of Septin Structure and Function
$380,581Erfei Bi · University Of Pennsylvania · R01 · FY2018 · GM
Molecular Analysis of Nerve Growth Factor Action
$380,576Moses Victor Chao · New York University School Of Medicine · R01 · FY2008 · NS
Molecular Analysis of Nerve Growth Factor Action
$380,576Moses Victor Chao · New York University School Of Medicine · R01 · FY2007 · NS
GI Endotoxin as an Environmental Trigger in an alpha-Synuclein Transgenic Mouse
$380,546Robert L Nussbaum · University Of California, San Francisco · R01 · FY2012 · ES
Neurochemical closed-loop controller for smart DBS
$380,518Luis Lujan · Mayo Clinic Rochester · R01 · FY2015 · NS
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA
$380,503Silke Nuber · Brigham And Women'S Hospital · R01 · FY2023 · NS
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA
$380,503Silke Nuber · Brigham And Women'S Hospital · R01 · FY2022 · NS
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA
$380,503Silke Nuber · Brigham And Women'S Hospital · R01 · FY2020 · NS
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA
$380,503Silke Nuber · Brigham And Women'S Hospital · R01 · FY2021 · NS
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA
$380,503Silke Nuber · Brigham And Women'S Hospital · R01 · FY2019 · NS
Maintaining Mitochondrial Health into Old Age
$380,498Shane Rea · University Of Washington · R01 · FY2020 · AG
Functional neural circuitry for decision making in the superior colliculus
$380,492Gidon S Felsen · University Of Colorado Denver · R01 · FY2024 · NS
Discovery and characterization of selective D4R antagonists and their evaluation in preclinical models of PD-LIDs
$380,470Corey R. Hopkins · University Of Nebraska Medical Center · R01 · FY2021 · NS
Hydrogen exchange, proteins, folding, and misfolding
$380,452S. Walter Englander · University Of Pennsylvania · R01 · FY2006 · GM
NEUROMODULATOR INFLUENCES ON PREFRONTAL CORTICAL FUNCTION
$380,415Christos Constantinidis · Wake Forest University Health Sciences · R01 · FY2015 · MH
Clinical and Education Core
$380,409Howard I Hurtig · University Of Pennsylvania · P50 · FY2009 · NS
Nicotine and Cognition in Parkinsonism
$380,407Jay S Schneider · Thomas Jefferson University · R01 · FY2006 · DA
Toward a Mechanistic Understanding of Optimization Principles Underlying Hemiparetic Gait
$380,398James M. Finley · University Of Southern California · R01 · FY2022 · HD
Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia
$380,396Yuna Ayala · Saint Louis University · R01 · FY2021 · NS
Role of Bach1-mediated transcriptional regulation in neuroprotection
$380,315Bobby Thomas · Augusta University · R01 · FY2018 · NS